Objective: While iron de®ciency is regarded as the major cause of nutritional anaemia, changes in vitamins A, B 12 , C and E, folic acid and ribo¯avin status have also been linked to its development and control. This paper provides a systematic review of vitamin supplementation trials relating to the control of nutritional anaemia. Methods: A MEDLINE search was used to ®nd reports of vitamin supplementation trials that reported changes in anaemia or iron status. Results: Vitamin A can improve haematological indicators and enhance the ef®cacy of iron supplementation. Both folate and vitamin B 12 can cure and prevent megaloblastic anaemia. Ribo¯avin enhances the haematological response to iron, and its de®ciency may account for a signi®cant proportion of anaemia in many populations. Vitamin C enhances the absorption of dietary iron, although population-based data showing its ef®cacy in reducing anaemia or iron de®ciency are lacking. Vitamin E supplementation given to preterm infants has not reduced the severity of the anaemia of prematurity. Vitamin B 6 effectively treats sideroblastic anaemia. Multivitamin supplementation may raise haemoglobin (Hb) concentration, but few studies have isolated the effect of multivitamins from iron on haematological status. Conclusions: In general, the public health impact of vitamin supplementation in controlling anaemia is not clear. Neither are the complex interactions involving multiple vitamins in haematopoiesis suf®ciently understood to explain the observed variability in haematological responses to vitamins by age, population, vitamin mixture and dosages. Further research is needed to understand the roles of individual and combined vitamin de®ciencies on anaemia to design appropriate micronutrient interventions to prevent anaemia.
More than two billion people in the world, including an estimated two-thirds of children and women of reproductive age in developing countries, suffer from iron de®ciency 1 . Half of those de®cient in iron have or will develop anaemia, clinically de®ned as low blood Hb concentration or low haematocrit (Hct), the volume fraction of packed red cells, using various cut-offs suggested for different life-stage groups (Table 1) 2 . While low intake of bioavailable iron may be regarded as the underlying cause of anaemia in most instances, other widespread factors can produce or contribute to the disorder, including infections such as malaria and hookworm, dietary de®ciencies of other nutrients, malabsorption, blood loss, acquired immune de®ciency syndrome (AIDS), genetic defects such as sickle cell disease, metabolic disorders and repeated pregnancy 3±5 . Approximately 50% of women and children in Africa and South Asia, 25% in Latin America, and 10% in industrialized nations are anaemic 6 . Anaemia has been associated with numerous, poor health-related outcomes such as impaired cognition, reduced work capacity, increased maternal morbidity and mortality, low birth weight, and increased fetal and neonatal death 7±10 .
Controlled trials provide evidence that adequate iron supplementation improves iron status and prevents anaemia, but there are various physiological, economic, social and logistical obstacles to achieving its effectiveness in practice 5 . The maintenance of normal haematopoietic function also requires adequate levels of many other nutrients acting in concert. While de®ciencies of such accessory' nutrients may occur in isolation, they usually exist in combination. Unfortunately, the roles and mechanisms by which many nutrients in¯uence the pathogenesis or prevention of anaemia remain obscure. Figure 1 illustrates some of the basic features of iron metabolism and erythropoiesis, emphasizing points in the process at which certain vitamins may in¯uence iron de®ciency and anaemia. Vitamins such as vitamin A, folic acid, vitamin B 12 , ribo¯avin and vitamin B 6 , are necessary for the normal production of red blood cells, while others such as vitamins C and E protect mature red blood cells from premature destruction by free radical oxidation (Table 2) . Ribo¯avin, vitamin A and vitamin C may also prevent anaemia by improving intestinal absorption of iron, or by facilitating its mobilization from body stores. This paper explores the effects of these vitamins in the treatment and prevention of anaemia in human populations and identi®es areas for future research.
Methods
Controlled vitamin supplementation and forti®cation trials that reported changes in anaemia (by Hb or Hct indicators) or iron status were considered for review. Studies were identi®ed, ®rst, by a MEDLINE search using combinations of the following keywords: vitamin, multivitamin, nutrient, anaemia, haemoglobin, iron de®ciency and supplement. This was followed by a search of references cited by relevant studies, and a search of recent editions of non-MEDLINE nutrition journals. The search focused primarily on English-language human studies published since 1967, 0.39 6 Impaired haem synthesis, leading to impaired erythropoiesis although a number of seminal early papers are cited to provide historical perspective.
Vitamin A
An estimated 190±255 million preschool-aged children throughout the world are vitamin A de®cient, with some 3±5 million having xerophthalmia, and 500 000 becoming blind and dying each year 11±14 . Vitamin A de®ciency may be responsible for 25±35% of all early childhood deaths in high risk regions of the developing world, attributed to increased severity of infection in a de®cient state 15±17 . There appears to be a causal relationship between vitamin A de®ciency and anaemia. Early studies of vitamin A-de®cient rats reported haematological disturbances such as losses of haematopoietic tissue in bone marrow, hypochromia, depressed Hb concentration and splenic accumulation of haemosiderin. Interpretation of these effects was complicated by results from other studies showing that initial declines in Hb levels and erythrocyte counts were followed by increases in packed cell volumes and Hb levels as de®ciency progressed, creating apparent polycythaemia rather than anaemia 18±21 . The increase in blood Hb level seen in some studies has been attributed to haemoconcentration resulting from dehydration and diarrhoea associated with severe vitamin A de®ciency 20 .
Restoration of vitamin A to the diet of de®cient animals was followed by regeneration of the bone marrow, disappearance of haemosiderin from the spleen and liver, and enhanced erythroblastic activity 22 . In humans, cross-sectional studies show positive correlations between serum retinol concentration and Hb that are more apparent with poorer vitamin A status and possibly age, at least in children. Chronically mild to moderately vitamin A-de®cient children are more likely to be anaemic than their non-de®cient peers 13 . Six Central American nutrition surveys and biochemical studies in Ethiopia and Bangladesh observed modest, positive correlations between circulating retinol and Hb levels in children (r c.0.21), suggesting that serum retinol accounts for 4±10% of the variation in Hb concentration 23±25 . The correlation was slightly stronger among severely vitamin A-de®cient school-aged children (r c.0.31) 23 . A weaker relationship was observed in Central American children aged 1±4 years (r c.0.13, P . 0.05) 23 . Although no association was observed among 1±8-year-old hyporetinolaemic Thai children 26 , a strong correlation (r c.0.52) between Hb and plasma retinol concentration was observed among anaemic (Hb , 110 g l ), malnourished school-aged Indian children 27 . An even stronger mean correlation (overall r = 0.78) between Hb and plasma retinol was reported from nutritional surveys of non-pregnant, non-lactating women of reproductive age in eight developing countries 28 . Intervention trials among women, however, suggest a more complex relationship (see below).
Positive haematological responses to vitamin A, most consistently re¯ected in increased Hb and serum iron concentrations, have been observed among children and pregnant women, whether the vitamin A was delivered as a regular supplement, a single dose or a forti®ed food item. Mejia and Arroyave found that 6 months after the start of a vitamin A sugar-forti®cation programme that provided approximately 330±360 mg retinol equivalents (RE) per child per day, serum iron levels of preschool children had increased (0.81 mmol l -1
) and serum ferritin concentrations had declined (-3.0 mg l -1 ), suggesting that existing body iron stores were mobilized to increase iron availability to tissues 29 . After 18 and 24 months, serum iron, transferrin saturation and serum ferritin were higher than baseline levels 29, 30 . While strongly suggestive of a vitamin A response, there was no comparison group against which these changes could be judged, and Hb concentrations were not measured.
Vitamin A trials employing concurrent comparison groups to evaluate impact on anaemia are summarized in Table 3 . Among Indonesian preschoolers, consuming c.240 mg RE day -1 from vitamin A-forti®ed monosodium glutamate (MSG) for 5 months signi®cantly increased Hb concentration by c.10 g l -1
, while Hb concentrations in a concurrent control group remained about the same (-2 g l -1 ) 31 . Hb did not increase further after six additional months of vitamin A-forti®ed MSG intake despite continued improvement in vitamin A status, suggesting that dietary iron, or possibly other anaemia prevention measures, may have been required to further improve Hb concentration 13, 31 . Mejia and Chew studied the effect of supplementing anaemic Guatemalan children aged 1±8 years daily with vitamin A (1500±3000 mg RE) or iron (3 mg kg , transferrin saturation by 3%, and Hb by 9 g l -1 but had no effect on serum ferritin (i.e. apparent iron stores). Vitamin A plus iron produced positive gains in Hb (14 g l -1
) and ferritin (5 mg l -1
), but these increments were similar to the responses observed with iron alone. Vitamin A and iron combined, however, increased transferrin saturation (by another c.5%) and serum iron (by another 4 mmol l . In contrast, other studies have shown high-potency vitamin A to elevate Hb and serum iron but not serum ferritin 39 . Among anaemic and mildly vitamin Ade®cient pregnant women in India, a single 60 000 mg RE dose of vitamin A added to daily supplementation of iron and folic acid resulted in a mean increase in Hb concentration (of 2 g l ) and Hct, and, compared to treatment with iron and folic acid alone, lessened the severity of the decline in serum iron 41 . A similar (but in this case, not statistically signi®cant) rise in Hb concentration of 3 g l -1 was obtained in non-pregnant, anaemic Bangladeshi women in response to a large, single oral dose of vitamin A (200 000 IU) when given with daily iron relative to iron alone 42 . A combination of vitamin A with daily iron and zinc raised Hb concentration by 5 g l -1 (P , 0.05) above that associated with iron alone. The greater response observed in the presence of zinc could re¯ect increased vitamin A mobilization, as zinc supplementation has been associated with increases in plasma vitamin A and retinol-binding protein 43 . Parasitic infections may modify the impact of vitamin A on anaemia. Among predominantly anaemic pregnant women in Nepal receiving 7000 mg RE week -1 , anaemia was reduced by c.9% during pregnancy and postpartum relative to a placebo group 44 . Vitamin A, however, was unable to compensate for the effect of blood loss associated with hookworm infection: there was no measurable effect of vitamin A among heavily hookworm-infected women (.1000 eggs g -1 ). Among women having light or no worm load, the prevalence of iron de®ciency anaemia (Hb , 110 g l -1 with erythrocyte protoporphyrin . 90 mmol mol -1 or serum ferritin , 12 mg l -1 ) was 46% lower in the vitamin A group relative to the placebo group.
Vitamin A de®ciency may induce anaemia by impairing the differentiation and proliferation of pluripotent haematopoietic cells 13, 45, 46 ; disturbing renal and hepatic erythropoietin synthesis 47 ; reducing mobilization of body iron stores and disturbing iron and haem metabolism 13, 48 ; through sequestration of iron during the acute phase response to infection 49, 50 ; or via other mechanisms such as iron absorption (Fig. 1) . In Venezuela, for example, provitamin A carotenoid enrichment increased iron absorption from cereals such as corn, rice and wheat, and appeared to counteract inhibitory effects of tea and coffee served with meals 51, 52 . In summary, vitamin A de®ciency is consistent in its association with anaemia. Vitamin A supplementation can generally be expected to:
1. Increase Hb and serum ferritin concentrations of anaemic children and pregnant women. 2. Improve the iron supply to haematopoietic tissue, possibly by enhancing the mobilization of iron delivery, and increasing plasma iron and transferrin saturation.
Folate
Alongside iron and vitamin B 12 , folate is a central component of human erythropoiesis, and although widely distributed in foods, especially green leaves (`foliage'), dietary folate de®ciency is the leading cause of megaloblastic anaemia in the world 53 . When de®cient in folate, the synthesis phase of cell division is prolonged, and germ cell maturation is retarded, leading, in the case of bone marrow, to abnormal red cell precursors (megaloblasts) that have larger than normal cell and nuclear diameters 54±57 .
Megaloblasts undergo grossly disturbed cell proliferation, and those that mature are often ingested and degraded by bone marrow macrophages. As a result, erythropoiesis is ineffective, the rate of delivery of new erythrocytes into circulation is depressed, and a macrocytic anaemia gradually develops (Fig. 1) . Haematologically, this may be re¯ected in a high mean (corpuscular) cell volume (MCV) and low Hb concentration 57 . Pregnant women are at high risk for folate de®ciency and megaloblastic anaemia during pregnancy 58±60 . Preterm infants have lower folate body stores at birth and higher growth demands as almost two-thirds of preterm infants experience low serum folate levels between 1 and 3 months of age 53,61±63 . Populations in malaria-endemic regions are at a high risk of folate de®ciency, as well. The extensive haemolysis brought on by malaria stimulates erythroid hyperplasia and drastically increases the requirement for folate, making malaria during pregnancy the most common cause of megaloblastic erythropoiesis in West Africa 64 . , compared to placebo, iron alone or iron in combination with vitamin B 12 . One study, in South Africa, has reported a signi®cant improvement in Hb 75 . Women receiving 300±1000 mg day -1 of folate, as forti®ed maize, during the last month of pregnancy exhibited Hb gains of 5.0±8.5 g l -1 compared to a Hb decline of -6.9 g l -1 among women receiving unforti®ed maize. These results would be unexpected, given that women were not anaemic at baseline, and the study lasted for only a few weeks.
Although these trials indicate that folate supplementation fails to raise Hb concentration or lower the risk of anaemia, it can prevent development of megaloblastosis. For example, in a randomized, placebo-controlled trial among non-anaemic pregnant women in Australia, folic acid supplementation signi®cantly reduced the percentage of hypersegmented neutrophils by the time of delivery 74 . In a second trial, among 200 primigravids in Nigeria, 8% of women receiving daily folic acid with antimalarial prophylaxis exhibited megaloblastic erythropoiesis (based on blood examination of red cell morphology) at follow-up compared to 25% receiving antimalarial prophylaxis without folic acid and 56% in the placebo group 76 . Folic acid has also had little effect on Hb concentration among non-pregnant women. Three months of daily supplementation with 1 mg folic acid and multivitamin during the postpartum period produced slight, though signi®cant, increases in mean Hb and Hct levels (2 g l -1 and and 0.008, respectively) compared to multivitamin use alone among lactating American women 77 . However, no bene®t of folic acid supplementation on Hb response was observed in trials among either non-pregnant Thai women 67 or Malaysian adolescent girls 78 . In the latter study, however, plasma ferritin increased signi®cantly following supplementation with iron and folate, but decreased in the folate-alone group, suggesting that folate may have stimulated synthesis of Hb from existing iron stores. In Thai school-aged children, hospitalized for malaria, 5 weeks of folic acid supplementation (15 mg day ), failed to increase Hb and Hct levels beyond those achieved by placebo 79 . Premature and low birth weight infants are highly susceptible to folate de®ciency in the ®rst year of life, and megaloblastic anaemia is common among them by 6±8 weeks of age 80 . However, in this age group as well, Hb appears to respond poorly to folate supplementation. In Britain, parenteral folic acid 61 and oral folic acid 81 given to low birth weight infants failed to improve Hb concentrations, while in a third trial 82 , oral folic acid (100 mg) appeared to temper the decline in Hb at 8 weeks and signi®cantly increase Hb by 23 g l -1 at 6 months. However, the folate group had signi®cantly higher Hb levels at baseline, the infants were not randomized, and the groups were fed differently 82 . Stronger evidence of Hb improvement has been observed. In southwest England, infants weighing , 2.5 kg received either 100 mg day . At 6 and 9 months, mean Hb was signi®cantly higher in the iron plus folate group compared with those receiving iron alone (by c. 4±5 g l -1
) and still slightly, but not signi®cantly, higher at 12 months. In a trial of 0.1 mg oral folic acid with or without 100 mg parenteral vitamin B 12 among premature infants weighing ,1800 g in the USA, Hb declined among all infants, reaching a nadir at age 10± 12 weeks. Relative to a mean Hb drop of 70 g l -1 in the control group, however, folic acid supplementation signi®cantly reduced the severity of the decline (-51 g l ), though by 6 months of age Hb concentrations were comparable in both folate-supplemented and control infants 84 . To conclude, folic acid de®ciency contributes to anaemia primarily by disrupting cell division which compromises erythropoiesis. Supplementation with folic acid is effective in treating and preventing severe folate de®ciency and overt megaloblastic anaemia. However, trials to date indicate that folic acid supplementation:
1. Has little effect on Hb concentration or Hct status among pregnant women. 2. May lessen the severity of anaemia of prematurity among young infants, although no large trials have 67 .
assessed the haematological effect of folate delivery to children.
Vitamin B 12
A second nutritional cause of megaloblastic anaemia is vitamin B 12 (cobalamin) de®ciency, which can produce macrocytic anaemia, as seen in folate de®ciency, as well as extensive neurological impairment. Vitamin B 12 is an essential cofactor in at least two key transmethylation reactions, one of which closely interrelates with folate in DNA synthesis and haematopoiesis. The conversion of homocysteine to the amino acid methionine requires a B 12 -dependent enzyme as well as a methyl group donated by the folate compound 5-methyltetrahydrofolate (5-methylTHFA). With de®ciency of vitamin B 12 , the enzyme function is disrupted, methionine formation is impaired, and both 5-methylTHFA and homocysteine accumulate. Through either the trapping of folate in the form of 5-methylTHFA or the failure of methionine synthesis, the levels of the folate compound 5,10-methyleneTHFA are reduced, ultimately leading to impaired synthesis of thymidine. An inadequate supply of thymidine, in turn, impairs DNA synthesis, potentially leading to megaloblastosis and anaemia (Fig. 1 ) 57 . Dietary B 12 de®ciency occurs less frequently than folate de®ciency, usually resulting from defective absorption rather than insuf®cient intake 85 . In particular, it is commonly the result of a pathological failure or reduction in the secretion of intrinsic factor, the glycoprotein that binds to and facilitates the transport of vitamin B 12 into the epithelial cells of the small intestine, a condition referred to as pernicious anaemia 57 . The only natural source of vitamin B 12 is its synthesis by certain algae, fungi and bacteria. The best dietary sources are meat products in which B 12 has accumulated, via either the animal's ingestion of B 12 -containing microorganisms or the synthesis of B 12 by the animal's gut¯ora; higher plants contain virtually no vitamin B 12 unless contaminated by microorganisms 86 . Body stores of B 12 among normal, healthy adults are large and would take an estimated 3±4 years of zero intake (and perhaps 20 years of low intake) to deplete, due to an ef®cient enterohepatic circulation that recycles B 12 from bile and other intestinal secretions 87 . However, several studies have observed that pregnant women who are strict vegetarians or who consume only minimal amounts of meat products are at high risk for becoming B 12 de®cient during pregnancy and lactation 88, 89 . Few studies have assessed the haematological bene®t of prophylactic vitamin B 12 supplementation (Table 5) , and those studies that have addressed anaemia have either not been designed to isolate the effects of B 12 from those of iron or folate, or have shown no additional haematological improvement associated with B 12 . In Israel, 90% of anaemic pregnant women supplemented with 100 mg iron, 5 mg folic acid and 100 mg B 12 
, compared with only 22% in the placebo group, although the speci®c effect of B 12 remained unknown 90 . Among pregnant women in Hyderabad, India, 2 mg oral B 12 added to 30 mg iron and 500 mg folic acid did not produce a response in Hb concentration signi®cantly different from that of iron and folic acid alone 71 . Among anaemic pregnant women in New Delhi, 10 mg B 12 , either alone or in combination with iron and folate, appeared to have no effect on Hb concentration, although the sample size was small and supplementation lasted only 4 weeks 68 .
) from a combination of parenteral B 12 and folate when given with iron, but the study was not designed to distinguish between the effects of B 12 and folate 69 . The strongest evidence of haematological bene®t appears to be among premature infants. In Florida, premature, low birth weight infants were randomized to receive, in addition to their standard treatment of iron and vitamin E, 0.1 mg day -1 oral folate, 100 mg month -1 parenteral B 12 , folate with B 12 or no additional supplementation, in order to assess differences in the severity of decline in Hb concentration that typically occurs in such infants 84 . Groups receiving B 12 experienced the least decline, with Hb concentrations falling 10±18 g l -1 less than unsupplemented or folate-alone groups. By 6 months of age, the infants who had received B 12 , either with or without folate, had a signi®cantly higher mean Hb level than both the unsupplemented and folate-alone groups.
To summarize, de®ciency of vitamin B 12 is less common than that of folate, but treatment of megaloblastic anaemia with folate alone can mask concomitant vitamin B 12 de®ciency, which can lead to severe neurological sequelae. Thus, megaloblastic anaemia should be treated with both folate and vitamin B 12 . Few studies have reported the haematological effects of vitamin B 12 beyond preventing megaloblastosis. Those conducted suggest that B 12 supplementation:
1. Has no effect on the Hb level of pregnant women. 2. May improve Hb status and reduce the severity of the anaemia of prematurity among premature and low birth weight infants.
Ribo¯avin
Ribo¯avin (vitamin B 2 ) de®ciency has been associated with the development of normochromic, normocytic anaemia that responds favourably to ribo¯avin supplementation 91, 92 . Although ribo¯avin is ubiquitous in foodstuffs, ribo¯avin de®ciency may be one of the most common vitamin de®ciencies among the people of developing nations, particularly in those regions where diets are predominantly rice-based and contain insuf®cient milk, meat, ®sh, fresh fruit or vegetables 93 . In vitro and in vivo studies have described a ribo¯avin-dependent mechanism for iron mobilization in which ā avin mononucleotide (FMN)-dependent oxidoreductase catalyses the removal of iron from storage ferritin and makes it available for utilization in haem synthesis (Fig.  1 ) 94, 95 . There is also an FMN-dependent oxidase instrumental in the conversion of vitamin B 6 to its active form, which ultimately stimulates globin production. In one clinical study, ribo¯avin supplementation produced a three-fold increase in erythrocyte B 6 conversion, followed by a rise in a-and b-globin chain synthesis 96 . Another possibility suggested by animal studies is that ribo¯avin affects iron absorption by maintaining the absorptive capacity of gastrointestinal villi, but studies among humans have not yet observed measurable change in iron absorption following ribo¯avin supplementation 97, 98 . Table 6 summarizes ribo¯avin supplementation trials that have assessed effects on anaemia. Results have been mixed, but several have shown that ribo¯avin can signi®cantly improve haematological status and augment the response to iron supplementation. A European study of mildly anaemic pregnant women showed that those who had received daily ribo¯avin (9 mg) along with iron (60 mg) maintained their erythrocyte counts and Hb and Hct levels while an iron-alone group showed signi®cant reductions in all three indices 99 . In the Gambia, marginally anaemic pregnant or lactating women were randomly allocated to receive daily iron (30 mg), ribo¯avin (5 mg), or both, for 6 weeks 100 . There were no signi®cant responses in Hb or Hct to any iron or ribo¯avin regimen. Unexpectedly, ribo¯avin appeared to lower Hb by c. 10 g l -1
among pregnant women, although a small sample size limited the difference from reaching statistical signi®cance. Lactating women receiving both iron and ribo¯avin had signi®cant increases in plasma iron and ferritin, whereas those receiving iron or ribo¯avin alone did not. The 6-week duration of supplementation may have been too brief to elicit more substantial responses.
Ribo¯avin-de®cient European children aged 9±12 years receiving 3 mg ribo¯avin exhibited a non-signi®cant increase of 3 g l -1 in Hb concentration after 3 months, compared with a 4 g l -1 decrease in the control group 101 . The Hb increase (7 g l . In a placebocontrolled trial among mostly anaemic 6±12-year-old Thai children, 6 mg of daily ribo¯avin with 40 mg iron increased mean Hb by 4 g l -1 above that achieved with iron alone (P , 0.005) 102 . Other studies among children have not observed signi®cant haematological effects. For example, in the Gambia, iron and ribo¯avin given at two different doses to ribo¯avin-de®cient 4±12-year-old children had no impact on iron status beyond that of iron supplementation alone 103 . Likewise, adolescents in Yugoslavia showed no response in mean Hb or Hct to 2 months of 2 mg day -1 ribo¯avin supplementation 104 . Unlike the negative ®ndings in Gambian children, however, ribo¯avin-de®cient Gambian men who received 5 mg of ribo¯avin with 40 mg day -1 of iron showed comparable changes in Hb concentration, but higher Hct, erythrocyte counts and serum ferritin after 6 weeks than men supplemented with iron alone 103 . In a subgroup of anaemic men, the bene®t of ribo¯avin appeared to be greater, producing a 23 g l -1 increase in mean Hb relative to 19 g l -1 in the iron-alone group. Improvement was also seen in Nigeria among 27 men and women who received placebo or 5 mg of ribo¯avin with or without 50 mg of ascorbic acid for 8 weeks in the absence of iron supplementation 105 . Erythrocyte counts, Hct and Hb levels all increased signi®cantly in the ribo¯avin-treated groups, with the greatest Hb increase (18 g l -1 ) produced by the combination of ribo¯avin and vitamin C.
Thus, ribo¯avin de®ciency may impair iron mobilization, globin synthesis and, possibly, iron absorption. Supplementation with ribo¯avin may:
1. Enhance the Hb, Hct and erythrocyte count response to iron supplementation during pregnancy. 2. Improve the haematological status of anaemic children and adults.
Vitamin C
Vitamin C de®ciency has been associated with various forms of anaemia, but it is still unclear whether vitamin C (ascorbate) is directly involved in haematopoiesis or if anaemia arises indirectly through the interactions of vitamin C with folate and iron metabolism 106 . In its role as a reducing agent, vitamin C can facilitate iron absorption from the gastrointestinal tract and enable its mobilization from storage (Fig. 1 ). Iron and ascorbate form an iron chelate complex that is more soluble in the alkaline environment of the small intestine and, as a result, more easily taken up 107±110 . Supplementation with vitamin C may augment the absorption of dietary iron. The simultaneous consumption of 25±75 mg of vitamin C has been shown to enhance four-fold or more the absorption of the less bioavailable, but more common, non-haem iron 109 . However, ascorbic acid must be consumed at about the same time as iron to be effective 111 . In addition, vitamin C may counteract the inhibition of iron absorption produced by dietary phytates and tannins 109 . Ascorbic acid also activates the enzyme folic acid reductase, to form tetrahydrofolic acid, the active form of folic acid, which prevents megaloblastic anaemia 106, 112 . Vitamin C may also prevent iron loss due to haemorrhaging associated with vitamin C de®ciency, or, possibly, prevent haemolysis resulting from compromised cellular antioxidant defence mechanisms 106, 113 . Vitamin C de®ciency is evident when serum ascorbate falls below 11.4 mmol l -1
. Inadequate status 114±116 is re¯ected by a serum ascorbate concentration of 11.5±17 mmol l -1
. Groups that have been identi®ed as being at risk of vitamin C de®ciency include pregnant and lactating women, infants fed exclusively cow's milk, elderly men and smokers 116±118 . A number of trials have assessed the effects of vitamin C supplementation on iron status and anaemia in children and adult pregnant and non-pregnant women (Table 7) . Anaemic preschool Indian children receiving 200 mg day , whereas Hb changed little among placebo controls 119 . In northeastern China, Hb increased signi®cantly by 3±6 g l -1 in a dose-responsive manner and serum ferritin rose by 14±28 mg l -1 , compared to placebo, among mildly anaemic preschool children receiving 50 mg or more of vitamin C daily for 2 months 120 . These studies support an adjunct role for vitamin C in modulating the risk of anaemia in malnourished child populations. Findings of no impact arise from a study of anaemic preschool Indonesian children whose Hb concentration failed to rise following 2 months of receiving 20 mg of vitamin C; however, lack of an adequate control group weakens the inference to be drawn from this study 121 . In Yugoslavia, 70 mg day -1 of ascorbic acid, given also for 2 months, failed to increase Hb or Hct among adolescent males, but the study population was not anaemic 122 . Vitamin C may exert a measurable haematological effect in non-pregnant women. Among 32 non-anaemic, Nigerian women, receipt of 50 mg or 100 mg day -1 of ascorbic acid signi®cantly raised Hb concentration by 18 and 20 g l , respectively, compared to a 4 g l -1 decline in unsupplemented controls 123 . In a controlled dietary experiment, 11 American women aged 22±36 years underwent iron stores depletion through a low-iron diet and phlebotomy and then were placed on an iron-replete diet, supplemented with either placebo or 1500 mg of ascorbic acid day -1 for 5.5 weeks 124 . Vitamin C recipients showed a slight, yet signi®cant, rise in Hb concentration (0.5 g l -1
) compared with the placebo group, whose mean Hb concentration declined by c. 3 g l -1
. Apparent iron absorption also signi®cantly rose among vitamin C recipients (to 38% vs. 27% for placebos), who retained an additional 2.3 mg day -1 of iron from their diets. However, serum ferritin concentration remained unaffected by ascorbic acid.
Non-anaemic, iron-de®cient women in Mexico were randomly assigned either lime juice containing 25 mg ascorbic acid or a lime-¯avoured placebo beverage to be consumed twice per day within 1 hour of meals 125 . After 6 months, gain in serum ferritin was consistently higher among supplemented women, representing an increase in iron absorption of up to 0.5 mg day -1
. Hb concentration was unaffected by supplementation, possibly due to inadequacy of the daily 50 mg vitamin C dose or to the initial absence of anaemia in subjects. However, negative ®ndings emerged from a trial among anaemic and nonanaemic pregnant Filipina women, where the addition of 100±300 mg of ascorbic acid to iron supplements daily for 16±18 weeks conferred no effect beyond that of iron alone in improving Hb concentration, Hct, serum iron or transferrin saturation by the time of delivery 126 . Non-experimental studies support a modest effect of vitamin C. For example, a study among Indian vegetarians observed signi®cant increases in Hb (by 8%), serum iron (by 17%) and serum ferritin (by 12%) from baseline following receipt of 500 mg of vitamin C after lunch and dinner for 2 months 127 . Providing well-nourished Turkish subjects with vitamin C (2 g) daily was associated with rises in Hb concentration (11 g l -1
) and serum iron (6 mmol l -1 ) after 1 month; however, levels were comparable to baseline after a second month of supplementation 128 . Lack of concurrent comparison groups weaken the results of both of these studies.
In summary, evidence is lacking to support a clear role for vitamin C in improving the haematological status of pregnant women. Small studies to date do suggest that vitamin C may:
1. Improve absorption of non-haem iron, protect against oxidative damage and counteract the effects of iron absorption inhibitors. 2. Increase serum iron, ferritin and Hb concentrations among children and non-pregnant subjects.
Vitamin E
Vitamin E (a-tocopherol) is a lipid-soluble compound that functions in humans primarily as an antioxidant, scavenging highly reactive free radicals and protecting the polyunsaturated fatty acids (PUFAs) of cellular membranes from oxidative destruction. Nutritional de®ciency of vitamin E is thought to be uncommon as it is widely distributed in foods, particularly vegetable and seed oils such as almond, sun¯ower, corn, soybean and wheat germ 106 . Susceptibility to de®ciency is largely limited to premature and low birth weight newborns and to various pathological malabsorption syndromes such as cystic ®brosis, biliary atresia and abetalipoproteinaemia 129 . Animal studies have observed the development of severe anaemia and morphological abnormalities of the bone marrow among primates on long-term vitamin Ede®cient diets 130, 131 . Treatment with vitamin E stimulated reticulocytosis and improved blood parameters among these animals 132 . Abnormal erythropoiesis, impaired iron metabolism and decreased erythrocyte survival times have also been observed in vitamin E-de®cient animals 130, 133, 134 . In humans, vitamin E supplementation has been shown to increase the reticulocyte count 135 . Preterm and low birth weight infants are born with low serum and tissue concentrations of vitamin E, due in part to limited placental transport of tocopherols and to scarcity of storage adipose tissue 129, 136 . Vitamin E de®ciency-induced anaemia in infants 6±12 weeks of age has been characterized by red blood cell haemolysis, reticulocytosis, . However, in these landmark studies, improvement in Hb status following vitamin E supplementation occurred only among infants consuming a low tocopherol to PUFA ratio in their diet and receiving concurrent iron supplementation 139,142±144 . It was soon recognized that infant formula diets rich in PUFAs and low in a-tocopherol, especially in the presence of oxidant compounds such as iron, potentiated the severity of de®ciency and haemolytic anaemia. Promotion of early breast-feeding, modi®cations in modern infant formulas to lower PUFA and iron levels, and routine vitamin E supplementation have virtually eliminated severe vitamin E de®ciency in premature infants 106, 145 . Randomized, placebo-controlled trials have examined the effect of vitamin E supplementation in preventing anaemia of prematurity among infants fed modern diets relatively low in PUFAs and iron (Table 8) . Two, in Canada, among low birth weight infants, failed to improve Hb concentration, reticulocyte count or erythrocyte morphology after 6 weeks of supplementation with 16 mg day -1 of vitamin E
146±148
. In England, preterm, low birth weight infants receiving either 5 or 15 mg day -1 of vitamin E had higher, albeit not signi®cantly, Hb values than the control group at 10 weeks of age 149 . Similarly, a small Brazilian trial failed to ®nd signi®cant differences in Hb concentration, Hct or indicators of reticulocytosis among premature low birth weight infants treated for 6 weeks with iron, vitamin E or both 150 . The potential bene®ts of vitamin E supplementation may have been masked in these trials because the diets of premature, low birth weight infants commonly contain vitamin E.
Non-experimental studies among anaemic, malnourished infants and children in Jordan 151 and Thailand 152 observed reticulocytosis and increases in Hb concentration and Hct following supplementation with oral vitamin E, but subsequent studies in India and Lebanon could not corroborate the response to vitamin E supplementation 153, 154 . Lack of randomization and concurrent control groups leads to caution in interpreting the ®ndings of these studies. However, a randomized, controlled trial among anaemic 1±3-year-old, protein-energy malnourished children in Thailand reported no additional improvements in Hb and reticulocyte counts from vitamin E given with iron relative to iron alone 155 . To summarize, vitamin E is routinely given to preterm infants in developed countries to protect against the potential oxidative damage caused by iron supplementation. Under existing regimens to provide vitamin E to premature infants, additional supplementation with vitamin E has not further reduced the severity of anaemia of prematurity.
Thiamine, niacin, pantothenic acid and vitamin B 6 Each of these four vitamins has been related to the development or treatment of anaemia during de®ciency and supplementation, respectively, and warrants mention, although their public health signi®cance with respect to anaemia is largely unknown. Thiamine-responsive megaloblastic anaemia, for example, is the product of a hereditary disorder of metabolism, part of a syndrome that is also characterized by diabetes mellitus and sensorineural deafness 156 . Niacin de®ciency has produced macrocytic anaemia in some animal models, and normocytic anaemia has been reported among human patients with pellagra, but the anaemia cannot be speci®cally attributed to de®ciency of niacin 157, 158 . Animal studies have also observed anaemia following induced de®ciency of pantothenic acid, but there has been only anecdotal evidence for the occurrence of pantothenic acid-responsive anaemia in humans 159±161 . No studies have been conducted to determine if these vitamins enhance erythropoiesis among malnourished populations.
Vitamin B 6 (pyridoxine) de®ciency can disturb haem synthesis and lead to normocytic, microcytic or sideroblastic anaemia (Fig. 1) . Treatment of sideroblastic anaemia with vitamin B 6 has resulted in the restored activity of erythroblastic d-aminolevulinic acid synthetase (ALAS), the rate-limiting enzyme in haem synthesis, followed by correction of the haematological abnormalities 162, 163 . In Germany, after treating children hospitalized with iron de®ciency anaemia for 8 days with iron plus vitamin B 6 , there was an apparent acceleration of haem synthesis, re¯ected in Hb concentrations that were higher than observed in children who received only iron (Table  9) 164 . Perhaps not surprisingly, supplementation of nonanaemic adolescents in Yugoslavia with 2 mg of vitamin B 6 daily for 2 months had no signi®cant effect on Hb or Hct status relative to placebo 104 . Vitamin B 6 may also inhibit sickling of erythrocytes in sickle-cell anaemia (SCA), possibly increasing erythrocyte counts, Hb concentrations and Hct among SCA patients 165 .
To recapitulate:
1. Thiamine, niacin and pantothenic acid have been related to human anaemia, but their public health signi®cance with respect to anaemia is questionable. 2. Vitamin B 6 de®ciency is rare, but treatment with B 6 may be effective in correcting the haematological abnormalities of sideroblastic anaemia.
Multivitamin supplementation
Studies previously cited have assessed the haematological effects of a single vitamin or small number of vitamins combined, with or without iron, but few trials have examined the haematopoietic impact of multivitamin supplementation. Most trials that have assessed the impact of multivitamin supplementation have used multivitamins with iron, and have not differentiated the effects of the vitamins from those obtained from iron alone. Table 10 summarizes a complex series of (70) VE alone for 6 weeks followed by VE Fe for 6 weeks 23.0 only after Fe was Fe alone for 6 weeks followed by VE Fe for 6 weeks 23.5 given multivitamin supplementation trials that have assessed outcomes relating to anaemia. In Peru, 10 weeks of daily multivitamin supplement use (containing thiamin, ribo¯avin, B 12 , folate and niacin) added to iron had no effect over iron alone on Hb levels of children aged 7±13 years 166 . Among preschool anaemic children in Germany, however, a combination of iron, folate, vitamin C, ribo¯avin, B 6 and B 12 for just 9 days raised mean Hb concentration 5 g l -1 above that of children receiving iron alone 167 . Russian school children were also reported to have shown signi®cant increases in Hb concentration and lower morbidity rates during 5±7 months of multivitamin supplementation (composition not described) compared to unsupplemented controls 168 . Signi®cant increases in serum iron and aerobic capacity were observed, compared with controls, in non-anaemic Yugoslav adolescents given daily ascorbic acid, ribo¯avin and B 6 for 3 months 169 . However, supplementation induced no signi®cant changes in Hb or Hct. In India, among children aged 6 months to 6 years, 100% of the children receiving only folate and B 12 for 12 weeks experienced some rise in Hb concentration, compared to 87% receiving only vitamins A and D, 92% receiving 40 mg of iron alone twice weekly, and 37% receiving placebo 170 . Among HIV-1-infected pregnant women in Tanzania, those taking multivitamins (either with or without vitamin A) had signi®cantly higher increases in mean Hb concentration at 6 weeks postpartum than did women not taking multivitamins (13 vs. 6 g l Other multivitamin studies have demonstrated haematological improvements, but have not been designed to isolate the haematological effects of vitamins from iron. In the Gambia, a seasonal decline in Hb due to malaria and hookworm among vitamin-de®cient prepubescent children appeared to be staunched somewhat by a multivitamin of thiamin, ribo¯avin, ascorbic acid and iron 171 . In China, a daily micronutrient-forti®ed weaning biscuit maintained the mean Hb concentration of infants aged 6±13 months, while Hb declined signi®cantly (-8 g l ) among infants receiving unforti®ed biscuits 172 . Among predominantly non-anaemic South African school children, biscuits forti®ed with iron, iodine and vitamin A along with a vitamin C-enriched drink signi®cantly improved Hb concentration 3 g l -1 more than supplementation with unforti®ed biscuits and placebo drink after 12 months 173 . Among 6±24-month-old Vietnamese children, a daily multivitamin (iron, vitamin A, vitamin C and zinc) or a higher-dose weekly multivitamin, produced highly signi®cant increases in mean Hb of 16 and 13 g l , respectively, and a reduction in the prevalence of anaemia from 50% to ,10%, compared to no change in Hb in the placebo group 174 . In Indonesia, among non-pregnant adolescent girls, 12 weeks of multivitamins containing either lower , respectively) 175 . A study in New Jersey examined the effects of prenatal multivitamin supplement (containing folic acid, calcium, zinc and iron) use by low income pregnant women on birth outcomes and blood ferritin, zinc and folate levels (Hb and Hct were not assessed) 176 . By 28 weeks' gestation, women who had used the multivitamins during their ®rst or second trimesters had higher serum ferritin values relative to non-users, indicating an improvement in iron stores.
In summary, the prevention and control of nutritional anaemia in many populations will probably require the use of multivitamin supplements. However:
1. Most ef®cacy studies of multivitamin supplement use to date have not differentiated the haematological effects of vitamins from those achieved with supplemental iron alone. 2. Thus, there is presently insuf®cient data among pregnant women, adolescent girls and children to assess the haematological bene®t of multivitamin supplementation, independent of the iron effect.
Conclusions
A large number of studies have evaluated the effects of single or multivitamin use on various health and nutritional outcomes in different population settings, but most have not been designed to adequately assess vitamin impact on Hb, Hct and other haematological measures. While consistency of effect can sometimes be gleaned for a particular nutrient or group of vitamins across diverse population groups, discrepant ®ndings tend more to be the rule than the exception within and between demographic, life-stage and geographic classes of subjects. Where consistency in effect exists, mechanisms at times can be invoked; discordance in effect between different groups of individuals leaves open a search for mechanisms both to explain the haematological effect and its variability.
The roles of most vitamins in controlling anaemia among high-risk populations have yet to be adequately explored. Among preschool-aged children, there is evidence that vitamins A and C can effectively raise haemoglobin levels, but no studies have been done to assess folic acid, vitamin B 12 , ribo¯avin or other vitamins. Among school-aged children, vitamin A has been effective, and there is some evidence that ribo¯avin can improve haematological status, but no large folic acid, vitamin C, E or B 6 studies have been conducted. Among pregnant women, evidence regarding the effectiveness of folic acid is still con¯icting; no studies have isolated the effects of vitamin B 12 ; evidence regarding ribo¯avin remains insuf®cient; and studies are needed to demonstrate the effects of vitamins C, E or B 6 in gravid women. Among non-pregnant women of reproductive age, vitamins A and C have been effective in improving haematological status; folic acid and ribo¯avin have been shown to be effective in small trials, but no studies have assessed the haematological effects of vitamins B 12 , B 6 or E. Perhaps most importantly, though, is a need for multivitamin supplementation studies among each of these populations that isolate the effects of vitamins from the haematological effects of iron supplementation. Further, there is a need for studies to compare the effectiveness of different vitamin combinations in order to examine possible interactions or enhancement of effects.
